PreserFlo microshunt leads to minimal transient anterior segment changes

VILAMOURA, Portugal — Minimally invasive glaucoma surgery with the PreserFlo microshunt leads to good IOP control with minimal anterior segment parameter variations, according to a study presented here.
“The purpose of our study was to evaluate anterior segment changes induced by PreserFlo implantation in the early postoperative period,” Matteo Carlà, MD, said at the European Society of Cataract and Refractive Surgeons winter meeting. “We included 48 eyes with uncontrolled primary open-angle glaucoma on maximum tolerated medications, both phakic and pseudophakic.”

VILAMOURA, Portugal — Minimally invasive glaucoma surgery with the PreserFlo microshunt leads to good IOP control with minimal anterior segment parameter variations, according to a study presented here.
“The purpose of our study was to evaluate anterior segment changes induced by PreserFlo implantation in the early postoperative period,” Matteo Carlà, MD, said at the European Society of Cataract and Refractive Surgeons winter meeting. “We included 48 eyes with uncontrolled primary open-angle glaucoma on maximum tolerated medications, both phakic and pseudophakic.”